Assessing glycemic control in patients with diabetes and end-stage renal failure (original) (raw)

Abstract

Blood glucose monitoring is important in optimizing long-term outcomes in diabetic patients. Reliance on near-patient testing and the use of longer term measures of glycation are the current cornerstones. However, as this review details, there are significant problems using blood tests as measures of metabolic control in uremic diabetic patients. Am J Kidney Dis 41:523-531.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (44)

  1. US Renal Data System: 1994 Annual Data Report. Am J Kidney Dis 24:S48-S56, 1994 (suppl 2)
  2. Mak RHK, DeFronzo RA: Glucose and insulin metab- olism in uremia. Nephron 61:375-382, 1992
  3. The Diabetes Control and Complication Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977- 986, 1993
  4. Molyneaux LM, Constantino MI, McGill M, Zilkens R, Yue DK: Better glycaemic control and risk reduction of diabetic complications in type 2 diabetes: Comparison with the DCCT. Diabetes Res Clin Pract 42:77-83, 1998
  5. Tzamaloukas AH, Murata GH, Zager PG, Eisenberg B, Avasthi PS: The relationship between glycaemic control and morbidity and mortality for diabetics on dialysis. ASAIO J 39:880-885, 1993
  6. Tzamaloukas AH, Yuan ZY, Murata GH, Balaskas E, Avasthi PS, Oreopoulos DG: Clinical associations of glycae- mic control in diabetics on CAPD. Adv Perit Dial 9:291- 294, 1993
  7. MoriokaT, Emoto M, Tabata T: Glycemic control is a predictor of survival for diabetic patients on hemodialysis. Diabetes Care 24:909-913, 2001
  8. Hayford JT, Weydert DA, Thompson RG: Validity of urine glucose measurements for estimating plasma glucose concentration. Diabetes Care 6:40-44, 1983
  9. Pickup JC: Diabetic control and its measurement, in
  10. Pickup J, Williams G (eds): Textbook of Diabetes (ed 2).
  11. Cambridge, MA, Blackwell Scientific, 2000, pp 30.1-30.15 10. Amiel SA, Gale EAM: Diagnostic tests in diabetes mellitus and hypoglycaemia, in Bouloux, Rees (eds): Diag- nostic Tests in Endocrinology and Diabetes (ed 1). New York, NY, Chapman & Hall Medical, 1994, pp 187-206 11. Anonymous: Consensus statement. Self-monitoring of blood glucose. Diabetes Care 16:60-65, 1993
  12. Mehmet S, Quan G, Thomas S, Goldsmith D: Impor- tant causes of hypoglycaemia in patients with diabetes on peritoneal dialysis. Diabet Med 18:679-682, 2001
  13. Janssen W, Harff G, Caers M, Schellekens A: Positive interference of icodextrin metabolites in some enzymatic glucose methods. Clin Chem 44:2379-2380, 1998 14. Bunn HF, Haney DM, Gabbay KH, Gallop PM: Further identification of the nature and linkage of the carbo- hydrate in haemoglobin A 1c . Biochem Biophys Res Com- mun 67:103-109, 1976 15. Bunn HF, Haney DN, Kamin S, Gabbay KH, Gallop PM: The biosynthesis of human haemoglobin A 1c . Slow glycosylation of haemoglobin in vivo. J Clin Invest 57:1652- 1659, 1976
  14. Gabbay KH, Sosenko JM, Banuchi GA, Mininsohn MJ, Fluckiger R: Glycosylated haemoglobins: Increased glycosylation of haemoglobin A in diabetic patients. Diabe- tes 28:337-340, 1979
  15. Fluckiger R, Woodtli T, Berger W: Quantification of glycosylated haemoglobin by boronate affinity chromatogra- phy. Diabetes 33:73-76, 1984
  16. Fitzgibbons JF, Koler RD, Jones RT: Red cell age- related changes in haemoglobin A 1a ϩ 1b and A 1c in normal individuals and diabetic subjects. J Clin Invest 58:820-824, 1976 19. Tahara Y, Shima K: The response of GHb to stepwise plasma glucose change over time in diabetic patients. Diabe- tes Care 16:1313-1314, 1993
  17. Trivelli LA, Ranney HM, Lai H-T: Hemoglobin com- ponents in patients with diabetes mellitus. N Engl J Med 284:353-357, 1971
  18. Koenig RJ, Peterson CM, Jones RL, Sauder C, Lehr- man M, Cerami A: Correlation of glucose regulation and hemoglobin A 1c in diabetes mellitus. N Engl J Med 295:417- 420, 1976
  19. Gonen B, Rubenstein AH, Rochman H, Tanega SP, Horwitz DL: Haemoglobin A 1c : An indicator of the meta- bolic control of diabetic patients. Lancet 2:734-737, 1977 23. Paisey RB, Macfarlane DG, Sherriff RJ, Hartog M, Slade RR, White DAJ: The relationship between blood glycosylated haemoglobin and home capillary blood glucose levels in diabetics. Diabetologia 19:31-34, 1980
  20. Gabbay KH, Hasty K, Breslow JL, Curtis Ellison R, Bunn FH, Gallop PM: Glycosylated hemoglobins and long- term blood glucose control in diabetes mellitus. J Clin Endocrinol Metab 44:859-864, 1977
  21. Casparie AF, Miedema K: Glycosylated haemoglobin in diabetes and renal failure. Lancet 2:758-759, 1977 26. deBoer M, Miedema K, Casparie AF: Glycosylated haemoglobin in renal failure. Diabetologia 18:437-440, 1980 27.
  22. Dandona P, Freedman D, Moorhead JF: Glycosylated haemoglobin in chronic renal failure. Br Med J I:1183-1184, 1979 28. Davenport A, Jones S, Goel S, Astley JP, Feest TG: Carbamylated hemoglobin: A potential marker for the ad- equacy of hemodialysis therapy in end-stage renal failure. Kidney Int 50:1344-1351, 1996
  23. Fluckiger R, Harmon W, Meier W, Loo S, Gabbay H: Hemoglobin carbamylation in uremia. N Engl J Med 304: 823-827, 1981
  24. Morgan L, Marenah C, Morgan A, Burden R, John W: Glycated haemoglobin and fructosamine in non-diabetic subjects with chronic renal failure. Nephrol Dial Transplant 5:868-873, 1990
  25. Smith W, Holden M, Benton M, Brown C: Glycosy- lated and carbamylated haemoglobin in uraemia. Nephrol Dial Transplant 4:96-100, 1989
  26. Paisey R, Banks R, Holton R, et al: Glycosylated haemoglobin in uraemia. Diabet Med 3:445-448, 1986 33. De Marchi S, Cecchin E, Basile A, et al: More on the increase in haemoglobin A1 in chronic renal failure: The role of acidosis. Nephron 35:49-53, 1983
  27. Freedman D, Dandona P, Fernando O, Moorhead JF: Glycosylated haemoglobin in chronic renal failure and after transplantation. J Clin Pathol 35:737-739, 1982 35. Eschbach JW Jr, Funk D, Adamson J, Kuhn I, Scrib- ner BH, Finch CA: Erythropoiesis in patients with renal failure undergoing chronic dialysis. N Engl J Med 276:653- 658, 1967
  28. Eschbach JW, Adamson JW: Anaemia of end-stage renal disease (ESRD). Kidney Int 28:1-5, 1985 37. Dolhofer R, Wieland OH: Improvement of the thiobar- bituric acid assay for serum glycosylyprotein determination. Clin Chim Acta 112:197-205, 1981
  29. Dolhofer R, Wieland OH: Glycosylation of serum albumin: Elevated glycosylalbumin in diabetic patients. FEBS Lett 103:282-286, 1979
  30. Schleider E, Wieland OH: Specific quantification by HPLC of protein (lysine) bound glucose in human serum albumin and other glycosylated proteins. J Clin Chem Clin Biochem 19:81-87, 1981
  31. Olufemi S, Talwar D, Robb DA: The relative extent of glycation of hemoglobin and albumin. Clin Chim Acta 163:125-136, 1987
  32. Johnson RN, Metcalf PA, Baker JR: Fructosamine: A new approach to the estimation of serum glycosylation. An index of diabetic control. Clin Chim Acta 127:87-95, 1982 42. Baker JR, O'Connor JP, Metcalf PA, Lawson MR, Johnson RN: Clinical usefulness of estimation of serum fructosamine concentration as a screening test for diabetes mellitus. BMJ 287:863-867, 1983
  33. Morris MA, Graudis AS, Littin JC: The correlations of glycosylated serum protein and glycosylated hemoglobin concentrations with blood glucose in diabetic pregnancy. Am J Obstet Gynecol 153:257-260, 1985
  34. Martina WV, Martijn EG, van der Molen M, Schermer JG, Muskiet FAJ: Beta-N-terminal glycohemoglobins in subjects with common hemoglobinopathies: Relationship with fructosamine and mean erythrocyte age. Clin Chem 39:2259-2265, 1993
  35. Ruilope LM, Garcia-Puig J: Hyperuricemia and renal function. Curr Hypertens Rep 3:197-202, 2001
  36. Cefalu W, Bell-Farrow A, Petty M, Izlarr C, Smith J: Clinical validity of a second generation fructosamine assay. Clin Chem 37:1252-1256, 1991
  37. Schleicher ED, Mayer R, Wagner EM, Gerbitz K-D: Is serum fructosamine assay specific for determination of glycated serum protein? Clin Chem 34:320-323, 1988 48. Lamb EJ, Fluck RJ, Venton TR, Woodhead JS, Raine AE, Dawnay AB: Effects of parathyroid hormones and 1,25(OH 2 )D 3 on protein glycation in moderate uraemia. Nephron 74:295-300, 1996
  38. Lamb E, Mainwaring-Burton R, Dawnay A: Effect of protein concentration on the formation of glycated albumin and fructosamine. Clin Chem 37:2138-2139, 1991
  39. Katirtzoglou A, Oreopoulos D, Husdan H, Leung M, Ogilvie R, Dombros N: Re-appraisal of protein losses in patients undergoing continuous ambulatory peritoneal dialy- sis. Nephron 26:230-233, 1980
  40. Wolfson M, Jones MR, Kopple JD: Amino acid losses during hemodialysis with infusion of amino acids and glu- cose. Kidney Int 21:500-506, 1982
  41. Ikizler TA, Pupim LB, Brouillette JR, et al: Hemodi- alysis stimulates muscle and whole body protein loss and alters substrate oxidation. Am J Physiol Endocrinol Metab 282:E107-E116, 2002
  42. Bilo HJG, Struijk DG, Boeschoten EW, Oe PL, Donker AJM: A comparison of three methods to assess metabolic control in diabetic patients on CAPD treatment. Neth J Med 33:217-224, 1988
  43. Nunoi K, Kodama T, Sato Y, et al: Comparison of reliability of plasma fructosamine and glycosylated hemoglo- bin assays for assessing glycemic control in diabetic patients on hemodialysis. Metabolism 40:986-989, 1991 55. Ichikawa H, Nagake Y, Takahashi M, et al: What is the best index of glycemic control in patients with diabetes mellitus on hemodialysis? Jpn J Nephrol 38:305-308, 1996 56. Morgan L, Marenah CB, Jeffcoate WJ, Morgan AG: Glycated proteins as indices of glycaemic control in diabetic patients with chronic renal failure. Diabet Med 13:1-6, 1996 57. Ansari A, Goldsmith D, Krimholtz M, et al: Measur- ing glycaemic control in renal failure. Diabet Med 18:70A, 2001 (abstr)
  44. Joy MS, Cefalu WT, Hogan SL, Nachman PH: Long- term glycaemic control measurements in diabetic patients receiving hemodialysis. Am J Kidney Dis 39:297-307, 2002 59. Covic A, Goldsmith DJA: Ambulatory BP monitor- ing-An essential tool for BP assessment in uraemic pa- tients. Nephrol Dial Transplant 17:1737-1741, 2002 60. Bode BW, Sabbah H, Davidson PC: What's ahead in glucose monitoring? New techniques hold promise for im- proved ease and accuracy. Med 109:41-44, 2001